Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing incidence of coccidiosis
3.2.1.2 Growing livestock population
3.2.1.3 Rising demand for animal protein
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of drug development
3.2.2.2 Stringent regulatory requirements
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Drug Class, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Synthetic compounds
5.3 Polyether antibiotics or ionophores
Chapter 6 Market Estimates and Forecast, By Drug Action, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Coccidiostatic
6.3 Coccidiocidal
Chapter 7 Market Estimates and Forecast, By Animal Type, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Companion animals
7.2.1 Dogs
7.2.2 Cats
7.2.3 Other companion animals
7.3 Livestock animals
7.3.1 Cattle
7.3.2 Poultry
7.3.3 Other livestock animals
Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Veterinary hospitals & pharmacies
8.3 Retail pharmacies
8.4 Other distribution channels
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Bayer AG
10.2 Boehringer Ingelheim International GmbH
10.3 Ceva
10.4 Cronus Pharma LLC
10.5 Elanco Animal Health Incorporated
10.6 Huvepharma EOOD
10.7 Impextraco NV
10.8 Merck & Co., Inc.
10.9 Phibro Animal Health Corporation
10.10 Vetoquinol SA
10.11 Virbac SA
10.12 Zoetis Inc.
